INS and Hypoglycemia: The use of basal insulin as a simple therapy with low risk of hypoglycemia combined with the recommended use of a clinical decision support tool in diabetes care (19) led to no severe hypoglycemic event and through continuous automated adjustments of insulin doses to stable insulin therapies with reduced glycemic variability and high adherence.